Merkel Cell Carcinoma

Also known as: Merkel Cell Carcinoma (MCC) / Merkel-cell Carcinoma / Merkel Cell Carcinoma (Disorder) / Carcinoma, Merkel Cell / Merkel cell carcinoma, unspecified / Merkel cell carcinoma (morphologic abnormality) / Apudoma of skin (disorder) / Neuroendocrine carcinoma of the skin

Drug	Drug Name	Drug Description
DB00958	Carboplatin	A alkylating agent used to treat advanced ovarian cancer.

Drug	Drug Name	Target	Type
DB00958	Carboplatin	DNA	target
DB00958	Carboplatin	High affinity copper uptake protein 1	transporter
DB00958	Carboplatin	Probable low affinity copper uptake protein 2	transporter
DB00958	Carboplatin	Xanthine dehydrogenase/oxidase	enzyme
DB00958	Carboplatin	Myeloperoxidase	enzyme
DB00958	Carboplatin	Glutathione S-transferase theta-1	enzyme
DB00958	Carboplatin	Metallothionein-1A	enzyme
DB00958	Carboplatin	Metallothionein-2	enzyme
DB00958	Carboplatin	Superoxide dismutase [Cu-Zn]	enzyme
DB00958	Carboplatin	Glutathione S-transferase P	enzyme
DB00958	Carboplatin	Glutathione S-transferase Mu 1	enzyme
DB00958	Carboplatin	NAD(P)H dehydrogenase [quinone] 1	enzyme
DB00958	Carboplatin	Copper-transporting ATPase 1	transporter
DB00958	Carboplatin	Copper-transporting ATPase 2	transporter
DB00958	Carboplatin	ATP-binding cassette sub-family G member 2	transporter
DB00958	Carboplatin	Canalicular multispecific organic anion transporter 1	transporter

Drug	Drug Name	Phase	Status	Count
DB11945	Avelumab	0	Recruiting	1
DB14707	Cemiplimab	0	Recruiting	1
DB06186	Ipilimumab	0	Recruiting	1
DB09035	Nivolumab	0	Recruiting	1
DB09037	Pembrolizumab	0	Recruiting	1
DB00041	Aldesleukin	1	Completed	1
DB13906	Aloe vera leaf	1	Completed	1
DB11595	Atezolizumab	1	Completed	1
DB01101	Capecitabine	1	Withdrawn	1
DB11059	Carboxymethylcellulose	1	Recruiting	1
DB14707	Cemiplimab	1	Recruiting	1
DB14322	Coconut oil	1	Completed	1
DB15770	Cosibelimab	1	Recruiting	1
DB00531	Cyclophosphamide	1	Completed	1
DB00531	Cyclophosphamide	1	Terminated	1
DB17506	Etrumadenant	1	Completed	1
DB01073	Fludarabine	1	Completed	1
DB01073	Fludarabine	1	Terminated	1
DB17244	G100	1	Completed	1
DB17293	Hiltonol	1	Active Not Recruiting	1
DB17293	Hiltonol	1	Recruiting	1
DB14865	Human interleukin-2	1	Terminated	1
DB08818	Hyaluronic acid	1	Completed	1
DB18396	IFx-Hu2.0	1	Active Not Recruiting	1
DB06186	Ipilimumab	1	Completed	1
DB12089	Lorvotuzumab mertansine	1	Completed	1
DB00123	Lysine	1	Recruiting	1
DB17480	Nanrilkefusp alfa	1	Active Not Recruiting	1
DB09035	Nivolumab	1	Completed	2
DB09035	Nivolumab	1	Recruiting	1
DB17116	Ontorpacept	1	Terminated	1
DB09037	Pembrolizumab	1	Active Not Recruiting	1
DB09037	Pembrolizumab	1	Completed	1
DB09037	Pembrolizumab	1	Recruiting	1
DB09037	Pembrolizumab	1	Terminated	1
DB01839	Propylene glycol	1	Completed	1
DB14272	Rosemary	1	Completed	1
DB00853	Temozolomide	1	Withdrawn	1
DB07232	Veliparib	1	Withdrawn	1
DB17505	Zimberelimab	1	Completed	1
DB08885	Aflibercept	1 / 2	Recruiting	1
DB00062	Albumin human	1 / 2	Recruiting	1
DB11595	Atezolizumab	1 / 2	Terminated	1
DB11945	Avelumab	1 / 2	Recruiting	1
DB11945	Avelumab	1 / 2	Withdrawn	1
DB15140	Bempegaldesleukin	1 / 2	Terminated	1
DB00112	Bevacizumab	1 / 2	Recruiting	1
DB00112	Bevacizumab	1 / 2	Withdrawn	1
DB17465	CD-16 NK-92 cells	1 / 2	Withdrawn	1
DB01101	Capecitabine	1 / 2	Withdrawn	1
DB00958	Carboplatin	1 / 2	Recruiting	1
DB00515	Cisplatin	1 / 2	Withdrawn	1
DB00531	Cyclophosphamide	1 / 2	Withdrawn	1
DB11714	Durvalumab	1 / 2	Completed	1
DB17529	ETBX-051	1 / 2	Withdrawn	1
DB17530	ETBX-061	1 / 2	Withdrawn	1
DB16395	Efineptakin alfa	1 / 2	Terminated	1
DB00544	Fluorouracil	1 / 2	Recruiting	1
DB00544	Fluorouracil	1 / 2	Withdrawn	1
DB17243	GI-101	1 / 2	Recruiting	1
DB17533	GI-6301	1 / 2	Withdrawn	1
DB17293	Hiltonol	1 / 2	Completed	1
DB14865	Human interleukin-2	1 / 2	Recruiting	1
DB16479	Inbakicept	1 / 2	Withdrawn	1
DB06186	Ipilimumab	1 / 2	Recruiting	1
DB00762	Irinotecan	1 / 2	Recruiting	1
DB09078	Lenvatinib	1 / 2	Recruiting	1
DB00650	Leucovorin	1 / 2	Recruiting	1
DB00650	Leucovorin	1 / 2	Withdrawn	1
DB17100	NEO-212	1 / 2	Recruiting	1
DB15299	Navtemadlin	1 / 2	Recruiting	1
DB09035	Nivolumab	1 / 2	Recruiting	1
DB09035	Nivolumab	1 / 2	Terminated	1
DB09567	Olive oil	1 / 2	Recruiting	1
DB09539	Omega-3-acid ethyl esters	1 / 2	Withdrawn	1
DB01229	Paclitaxel	1 / 2	Recruiting	1
DB01229	Paclitaxel	1 / 2	Withdrawn	1
DB09037	Pembrolizumab	1 / 2	Recruiting	4
DB09037	Pembrolizumab	1 / 2	Terminated	1
DB08896	Regorafenib	1 / 2	Recruiting	1
DB11836	Sapanisertib	1 / 2	Completed	1
DB11771	Tremelimumab	1 / 2	Completed	1
DB11702	Antineoplaston A10	2	Withdrawn	1
DB11595	Atezolizumab	2	Active Not Recruiting	1
DB11595	Atezolizumab	2	Recruiting	1
DB11945	Avelumab	2	Active Not Recruiting	2
DB11945	Avelumab	2	Completed	1
DB11945	Avelumab	2	Recruiting	3
DB11945	Avelumab	2	Terminated	1
DB11945	Avelumab	2	Withdrawn	1
DB17465	CD-16 NK-92 cells	2	Active Not Recruiting	1
DB17465	CD-16 NK-92 cells	2	Terminated	1
DB05153	Cabozantinib	2	Terminated	1
DB08875	Cabozantinib	2	Terminated	1
DB00958	Carboplatin	2	Completed	1
DB00958	Carboplatin	2	Not Yet Recruiting	1
DB14707	Cemiplimab	2	Recruiting	1
DB14707	Cemiplimab	2	Suspended	1
DB00515	Cisplatin	2	Not Yet Recruiting	1
DB00515	Cisplatin	2	Recruiting	1
DB00531	Cyclophosphamide	2	Recruiting	1
DB17157	Darleukin	2	Recruiting	1
DB17521	Domatinostat	2	Active Not Recruiting	1
DB17521	Domatinostat	2	Withdrawn	1
DB11714	Durvalumab	2	Active Not Recruiting	1
DB11714	Durvalumab	2	Recruiting	1
DB00773	Etoposide	2	Completed	1
DB00773	Etoposide	2	Not Yet Recruiting	1
DB00773	Etoposide	2	Recruiting	1
DB01073	Fludarabine	2	Recruiting	1
DB16479	Inbakicept	2	Active Not Recruiting	1
DB16479	Inbakicept	2	Terminated	1
DB06186	Ipilimumab	2	Active Not Recruiting	1
DB06186	Ipilimumab	2	Withdrawn	1
DB06791	Lanreotide	2	Completed	1
DB09078	Lenvatinib	2	Recruiting	1
DB00281	Lidocaine	2	Recruiting	1
DB13985	Lutetium Lu 177 dotatate	2	Recruiting	1
DB09035	Nivolumab	2	Active Not Recruiting	4
DB09035	Nivolumab	2	Recruiting	2
DB16269	Onfekafusp alfa	2	Recruiting	1
DB01229	Paclitaxel	2	Terminated	1
DB09037	Pembrolizumab	2	Active Not Recruiting	1
DB09037	Pembrolizumab	2	Not Yet Recruiting	1
DB09037	Pembrolizumab	2	Recruiting	3
DB09037	Pembrolizumab	2	Terminated	1
DB00750	Prilocaine	2	Recruiting	1
DB14851	Relatlimab	2	Recruiting	1
DB15766	Retifanlimab	2	Recruiting	2
DB13896	Talimogene laherparepvec	2	Active Not Recruiting	1
DB13896	Talimogene laherparepvec	2	Completed	1
DB17301	Tavokinogene telseplasmid	2	Completed	1
DB17500	Vidutolimod	2	Suspended	1
DB11595	Atezolizumab	3	Recruiting	1
DB14707	Cemiplimab	3	Recruiting	1
DB06186	Ipilimumab	3	Recruiting	1
DB09035	Nivolumab	3	Recruiting	1
DB09037	Pembrolizumab	3	Completed	1
DB09037	Pembrolizumab	3	Recruiting	1
DB18396	IFx-Hu2.0	Not Available	Available	1